STD Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research

The global STD (sexually transmitted disease) diagnostics market is driven by growing awareness about STDs among the masses and greater governmental initiatives. Technological developments too play a vital role in fuelling market growth. Popularity of POC (point of care) testing propels the demand for improved products, such as diagnostic devices, kits, and reagents. A number of people have multiple sexual partners which in turn raises the possibility of contracting infections. Hence, there’s the growing need for accurate & precise diagnostics solutions.

The worldwide STD diagnostics market is segmented as per types of infections, location of tests, devices, and regions. On the basis of infections, the categories are human papilloma virus (HPV), syphilis, chlamydia, vaginitis, HIV (human immunodeficiency virus), herpes simplex virus, and gonorrhea. Chlamydia, gonorrhea, and syphilis are sexually transmitted infections (STIs) caused by bacteria.

Browse Details of Report @ https://www.hexaresearch.com/research-report/std-diagnostics-market

Genital warts, HPV, HIV, and hepatitis genital herpes are examples of STIs caused by viruses. These microorganisms get transmitted through semen, blood, and vaginal fluids. Chlamydia is by far the most commonly occurring sexually transmitted disease. In terms of revenues, this segment held the highest share in the overall industry. It generated revenues surpassing USD 36 billion in 2016.  However, rising cases of syphilis may contribute to more than 20% of total industry revenues over the forecast period (2016 to 2024).

Based on location of tests, the market is bifurcated into laboratory testing and point of care (PoC) testing.

Laboratory tests are carried out either in public health labs or in private/commercial labs. Unlike, PoC testing solutions, laboratory tests deliver more precise results. PoC tests (such as test kits) are a more convenient option because these deliver immediate results, but they are not always accurate. The introduction of bedside & mobile testing is a step towards enhanced healthcare. The industry for bedside & mobile testing may expand at a CAGR nearly 10% from 2016 to 2024.

According to type of device, the worldwide STD diagnostics market is segmented into thermal cyclers - PCRs, lateral flow readers, flow cytometers, differential light scattering machines, absorbance microplate reader, phone chips (microfluidics+ICT), and bench top/portable/rapid diagnostics kits. Portable/rapid diagnostics and phone chips are PoC testing devices, while the others are laboratory test devices. The thermal cyclers segment is anticipated to grow rapidly at a CAGR surpassing 8% during the forecast period. The portable PoC testing devices industry is propelled by continuous technological innovations. It may generate revenues exceeding USD 46 billion by 2024.

Geographically, the global STD diagnostics market is divided into Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. Driven by surging public awareness about STIs and the presence of a well developed system of health insurance, North America dominates the global industry. Another vital factor that positively impacts this region is the growing accessibility to FDA-approved highly advanced testing devices. As per ongoing industry trends, Asia Pacific may register a high CAGR over the forecast period and thus prove to be a lucrative market in the long run. Prominent companies operating in the worldwide STD diagnostics market are Danaher Corporation, Abbott Laboratories, BioMerieux, Roche Holdings AG, and Becton Dickinson & Company.

Recently, QuantuMDx, a U.K. based company dealing in life sciences diagnostics & tools, developed the Q-Poc. This is a highly affordable diagnostic DNA analyzer which is commonly known as the “handheld lab”. It is capable of diagnosing certain types of cancers and a number of infectious diseases (including the sexually transmitted ones). Equipped with a solar battery, the Q-Poc can analyze biological samples, for example, swabs are used to detect sexually transmitted diseases/infections.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Stem Cell Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research

Factors that propel the global stem cell market are exhaustive R&D in therapeutic solutions and strong government support for drug discovery & related developments. Governmental support in the form of financial assistance helps fulfill a number of unmet healthcare needs. Rising cases of chronic diseases related to the liver, kidneys, and heart is another prominent factor that increases the popularity of stem cells technology. Stem cells refer to undifferentiated cells that have the capacity to regenerate and thus perform a number of functions. The growing importance of regenerative medical treatment is expected to drive the worldwide Market over the forecast period (2016 to 2024).

The four parameters based on which the global stem cell market is categorized are: products, technologies, applications, and geographies. Product-wise, the segments are human embryonic cell, pluripotent, and adult stem. Another term that defines pluripotent stem cells is “master” cells. These cells have the capacity to create cells from all three body layers. Hence, they can produce any tissue or cell that the body has to repair itself. They are self-perpetuating, that is they can develop several copies of themselves.

Browse Details of Report @ https://www.hexaresearch.com/research-report/stem-cell-industry

Embryonic stem cells are derived from the undifferentiated inner mass of cells present in a human embryo. Adult or somatic stem cells are found throughout the body and help regenerate damaged or dying cells & tissues. Adult stem cells are by far the most extensively used ones, because the human body can easily accept these cells. Furthermore, the possibility of contamination is also quite low. This segment will continue dominating the global Stem Cell Market during the forecast period. It generated revenues exceeding USD 30 billion in 2013.

Based on technologies, the global industry is categorized into cryopreservation, cell production, expansion, and cell acquisition. The overall market was dominated by the cell acquisition segment in 2013. This is the technique of obtaining stem cells from their sources. Cell culture, cloning, and in-vitro fertilization are the different techniques of cell acquisition. Bone marrow harvesting too is an integral part of such a technique. Regenerative medicine, drug discovery, and drug development are the various application areas of the global market. Ongoing trends in medicine suggest that stem cell based treatments are gradually gaining much importance in the management of diseases, such as Huntington’s chorea and Parkinson’s disease.

Based on geographies, the global stem cell market is segmented into Europe, Asia Pacific, North America, and Rest of the World. In terms of revenue, North America holds the highest share in the overall market. The region may continue expanding robustly over the forecast period because of widespread adoption of cell based therapies and high R&D investments by the public & private sectors. Asia Pacific too may expand rapidly during the same time because of medical tourism, high disposable incomes, and surging CRO (Contract Research Organization) activities. Prominent companies that hold significant shares in the global industry are Angel Biotechnology; California Stem Cell Inc.; Bioheart; Brainstorm Cell Therapeutics; and Celgene Corporation Inc.

Stemcells Inc., a California based biopharmaceutical company focuses on the development of purified human neural stem cells (HuCNS-SCs). In November 2016, the company entered a joint collaboration with Microbot Medical Ltd., a medical device company that specializes in developing & designing transformational micro-robotic technologies. With the help of highly precise & less invasive surgical solutions, these technologies aim at bettering the quality of life of patients all across the globe.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin : https://www.linkedin.com/company/hexa-research 

Glucose Biosensors Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 | Hexa Research

The worldwide glucose biosensors market size is expected to surpass USD 31 billion by 2024. It was valued about USD 15.3 billion in 2015. The high incidence of diabetes is a key factor that drives this market. Technological breakthroughs in monitoring glucose levels can spur market demand. Biosensors are devices that detect biological changes in the body and display those via electronic indicators. These changes (commonly known as analytes) could be gases, organic compounds, bacteria, and others.

Glucose biosensors can sense glucose levels within the body. They are small & minimally invasive devices that assess glucose levels in outpatient settings. Need for reliable biosensors still pose a market challenge. Alternative methods, like laboratory tests can restrict market growth. But several companies are investing in R&D (research and development) to improve the current technology.

Browse Details of Report@ https://www.hexaresearch.com/research-report/glucose-biosensors-market

The global Glucose Biosensors Market is segmented on the basis of types, end-users, and regions. The two types are amprometric and fluorescent. Amperometric biosensors are extensively available. They function by way of glucose oxidase. These devices combine glucose with oxygen to produce hydrogen peroxide. The electrode identifies hydrogen peroxide and accurately measures glucose levels from it.

Fluorescent biosensors are estimated to capture major market shares over the forecast period (2016-2024). These biosensors measure glucose levels by detecting sensitive proteins via the fluorescence process. Better operational life of these devices may benefit the market in the years ahead.

End-users are home care diagnostics, hospitals, and others. Others include diagnostic laboratories, research institutes, and clinical. Home care diagnostics held over 46% market shares in 2015. This segment comprises the adoption hand-held glucose meters. These devices deliver quick & efficient results and reduce the need for frequent hospital visits. ‘Hospitals’ may expand significantly over the next eight years. It could grow a 10.3% CAGR from 2015 to 2022.

Regions in the global Glucose Biosensors Market are North America, Latin America, Middle East & Africa (MEA), Asia Pacific, and Europe. North America dominated the worldwide market with nearly 37% shares in 2015. Growing cases of diabetes coupled with technological advancements in the region can boost revenues during the forecast period. Europe may be the second largest market in terms of revenue after North America.

Asia Pacific is expected to grow at a CAGR of 13% from 2015 to 2022. India & China jointly accounted for over 65% of the global diabetic base in 2013. This could benefit the worldwide market in the years ahead.

Major players in the glucose biosensor industry are LifeScan Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, and Bayer AG. These companies held over 70% of the total market shares in 2014. They focus on product development, partnerships, and collaborations for long term growth and market sustenance. For instance, LifeScan introduced a new glucose monitoring system, OneTouch Verio in 2015. It measures glucose levels via a color-coded indicator.

Mayo Clinic, Gentag, NovioSense, and Fraunhofer Institute for Microelectronic Circuits & Systems entered a collaboration to fight against type 2 diabetes, in 2015. They aim at equipping smartphones with low-cost diabetes monitoring systems. The technology thus developed may be employed in a number of diabetes applications, such as eye sensors, skin patches, long-terms implantable sensors and so on. All of these devices can be controlled via smartphones. Currently, carbon nanotubes are gaining popularity due to their exceptional physical and electrical properties. These nanotubes work well with glucose biosensors by providing support for enzyme control.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin : https://www.linkedin.com/company/hexa-research

Doxorubicin Market Growth, Industry Trends and Forecasts, 2016 to 2024 - Hexa Research

Doxorubicin is an anti-cancer chemotherapy drug. It is an intravenous injection through a central or peripheral venous line. No pill form of this drug is available in the market. Doxorubicin market is expected to witness a significant growth in the developed regions due to the multiple incidences of cancer occurrence in these regions. According to World Health Organization (WHO), in 2012, 14.1 million new cancer cases were detected worldwide.

Doxorubicin is an anthracycline chemotherapy drug that slows down the growth of cancer cells which is one of the primary reasons of its demand globally.. Four most common cancers worldwide are lung cancer, prostate cancer, female breast and bowel. Doxorubicin drug provides chemotherapy treatment for all four cancers which is anticipated to drive the industry in next eight years. Early diagnosis led to the longer duration of treatment which in turn increases the demand for doxorubicin drug. Increasing effectiveness of drug therapies are contributing to the higher spending on drugs for cancer care. Moreover, various government initiatives for controlling cancer and increasing its awareness through  governmental organizations such as Cancer Prevention And Control Research Network (CPCRN )and National Cancer Institute is creating to have a positive impact on the anti-cancer drug. Increased alcohol consumption, usage of tobacco coupled with lack of physical activity and unhealthy diet are considered to be main risk factors of cancer worldwide. According to WHO estimates, the mortality rate worldwide was 8.2 billion in 2012 and is expected to rise by about 70% in the near future. Due to aforementioned reasons, anti-cancer drug market revenues are anticipated to increase in the near future.

Browse Details of Report @ https://www.hexaresearch.com/upcoming-research/doxorubicin-market

Media is also playing an important role in spreading awareness about various diseases and related drugs. Consumer awareness of these drugs is expected to have a positive impact on the doxorubicin market. Support from non-profit organizations and regional government in UK on approval of drugs is anticipated to drive the market during the forecast period.

However, Doxorubicin therapy can cause a risk of developing leukemia and tumor lysis syndrome which can further lead to kidney failure is expected to act as a roadblock for the growth of doxorubicin market. This drug also has adverse effects and can cause skin rashes, itchy sensation, can lead patient feel short of breath, swelling of face, feeling dizzy and stomach ache. Moreover, it can cause extensive tissue damage and can develop dizziness among consumer. High treatment cost poses a challenge to this market. Also, pharmaceutical industries significantly rely on the R&D initiatives. Pharmaceutical agencies are focusing on new medicines in order to cater to the customer needs which may poses as a threat to this market in the long run.

The market can be segmented on the basis of cancer type. Doxorubicin treats number of cancers such as acute lymphoblastic leukemia, acute myeloblastic leukemia, bone sarcoma, breast cancer, endometrial cancer, gastric cancer, head and neck cancer, liver cancer, kidney cancer, ovarion cancer, small cell lung cancer, thyroid cancer and transitional cell bladder cancer. Drug used for treating thyroid cancer dominated the market in the recent past on account of growing incidences of thyroid cancer especially in UK.

The U.S. dominated the market in the near past on account approval of doxorubicin products by FDA and increasing number of cancer incidences. Europe is one of the major markets owing to increasing number of deaths due to cancer. Emerging nations such as India and China are anticipated to show a substantial growth rate based on the growing population, cancer incidences and tobacco consumption. Africa is expected to observe a lower growth rate owing to lack of consumer awareness and healthcare infrastructure, and expensive medication.

Key players in this market include Pfizer Inc., Dabur Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd., German Remedies Ltd., Biological E Ltd., Elder Pharmaceuticals Pvt. Ltd., Cipla Ltd., Sun Pharmaceuticals Industries Ltd., Natco Pharma Ltd., Biochem Pharmaceutical Industries Ltd., Pharmacia India Ltd., VHB Life Science Inc., Chandra Bhagat Pharma Pvt. Ltd., GLS Pharma Ltd., and Intas Laboratories Pvt. Ltd. Mergers and acquisitions in this industry is helping acquirer in building technical expertise and hold a library of patents.

In March 2015, Sun Pharmaceuticals Industries Ltd. acquired Ranbaxy Laboratories Ltd. to increase its presence in the global and domestic markets by filling therapeutic gaps in the U.S.

In February 2013, Sun Pharma’s Lipodox (doxorubicin hydrochloride liposome injection) was approved by FDA for the treatment of ovarian cancer in the patients.

Browse Related Category Market Reports@

https://www.hexaresearch.com/research-category/pharmaceuticals-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin: https://www.linkedin.com/company/hexa-research

Craniomaxillofacial Devices Market Size, Share, Growth, Industry Analysis and Forecast to 2024 | Hexa Research

The craniomaxillofacial (CMF) devices market is estimated to grow at a CAGR over 6% during the forecast period (2016-2024). Demand for minimal invasive procedures which can heal rapidly is the primary driving factor of the market. Awareness of these surgeries by ASCFS and ISCFS will facilitate in market growth. Bigger healthcare budget, use of 3D implants in reconstructive surgery, and growing geriatric populace are other aspects favoring the market.

The global market is segmented according to products, materials, applications, and regions. Products include cranial flap fixation, MF (maxillofacial) plate and screw-fixation, bone graft substitutes, and CMF distraction. Plate and screw fixation earned over 70% market revenue shares in 2014 due to their varied use in surgeries.

Browse Details of Report with TOC @ https://www.hexaresearch.com/research-report/craniomaxillofacial-market

Materials used are metal, bioabsorable, and alloys. Titanium alloys are used to produce cranial plates due to their low weight & non-corrosive property. Polymers such as PMMA (poly methyl methacrylate) and Medpor are used due to their biocompatible nature. Biomaterials such as PDLLA and PPEK are used in bioabsorbable devices.

Neurosurgery & ENT, orthognathic & dental, plastic surgery, and others constitute as market applications. Increasing cases of spinal disorders will bring in revenues from the neurosurgery & ENT segment. Plastic surgery will see growth in the years ahead from developed countries of Canada and U.S.

Regions covered under the market are Latin America, North America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for over 58% market revenue in 2014. Other factors supporting market growth in the region are technological developments, healthcare infrastructure, and high patient awareness.

Europe is in need of technology which can cater to plate and screw fixation, thoracic fixation, CMF bone graft substitutes, and temperomandibular joint (TMJ) replacement. This is expected to net revenues over USD 227 million in 2013. Asia Pacific will exhibit growth due to economic development and improving healthcare infrastructure.

Well-known players of the craniomaxillofacial devices market are Aesculap; Johnson & Johnson (DePuy Synthes); Boston Medical Products Inc.; and Medartis AG. Research and development of products are one of the strategies followed by players. For instance, Aesculap introduced Pro space, a osteoconductive interbody fusion method in 2015.

Browse Related Category Market Reports@

https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin: https://www.linkedin.com/company/hexa-research

3D Scanner Market Size, Analysis, Growth, Trends and Forecasts, 2016 To 2024 - Hexa Research

The global 3D scanner market is expected to reach USD 7.4 billion by 2024. It should grow at a CAGR over 11.5 % during 2016 to 2024 (forecast period). Wider adoption of these devices in applications; such as rapid prototyping, quality control, reverse engineering, etc. will augment growth of this industry. Software & hardware providers lay stress on workflow enhancement & usage convenience, thus boding well for the market and propelling its sales.  

The workflow is generally complicated for those new to 3D scanning. This coupled with costly scanners hampers the growth of 3D scanners. However, the demand for accurate, quick, & effective results primarily would drive the 3D scanner market. In addition to this, scanner properties; like affordability can also propel the market. ‘Handheld 3D scanner’ & technological expansion are projected to drive the industry demand in the near future. The market is categorized into products, ranges, applications, and regions.

Browse Details of Report @ https://www.hexaresearch.com/research-report/3d-scanner-market

Products include structured light, laser, and optical. Laser scanners led the market in 2013. However, optical and structured light are anticipated to grow rapidly. Optical scanners should grow at a healthy CAGR (over 11 %) during the forecast period. Ranges consist of short, medium, and long. Short range scanners dominated in 2013. They will maintain their dominance till 2024. Medium is likely to gain considerable shares, at a CAGR of 11 % till 2024. Long range is said to be growing slowly due to its high costs.

Applications in the 3D scanner market are aerospace & defense, industrial manufacturing, healthcare, entertainment & media, and engineering & architecture. Industrial manufacturing reigned in 2014, accounting for 30 % shares. 3D scanning can be a critical component of quality & inspection control across construction industry.

Entertainment & media should witness the highest growth. It is estimated to reach USD 600 million by 2024, at a healthy CAGR of 13 %. Rising significance of market devices in architecture may be attributed to the advent of portable 3D scanners. 3D scanners help in archiving and preserving architectural pieces from museums. Engineering & architecture will hold over 12.5 % shares by 2024.

Geographically, the worldwide 3D scanner market is fragmented on the basis of Europe, North America, Latin America, Asia-Pacific, and RoW. North America reigned in 2013 and can lead over the forecast period. Latin America is said to be the most lucrative region. It is predicted to exceed USD 750 million by 2024, at a CAGR of 13 % in the near future.

The same would be attributed to rising adoption of 3D scanners across various application and end-user industries. Asia-Pacific held over 23% shares in 2014. This region is expected to grow rapidly, surpassing incomes worth USD 1.5 billion by 2024. Major companies in the global market comprise Basis Software Inc. (Surphaser); 3D Digital Corp.; Topcon Corp.; and FARO Technologies.

The industry is marked by strong rivalry and often indulges in mergers & acquisitions. Firms cater to different sectors; like manufacturing, aerospace, education & research, and consumer goods. Introduction of ‘quality’ & ‘affordable’ 3D scanners provide future market prospects. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-imaging-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin : https://www.linkedin.com/company/hexa-research

Electrical Hospital Beds Market - Industry Analysis, Size, Growth and Forecasts to 2024 | Hexa Research

Exceptional access to a universe of data has offered ascend to the engaged, yet doubtful, customer. So is the situation with medicinal services, where the patient has been rendered more educated and reliable on account of the exceptional infiltration of the Internet. The perceiving persistent now requests more moderate, advanced, straightforward, and customized social insurance administrations, making the requirement for new models for consideration. The healing center beds industry taking into account treatment has made gigantic development in the late years.

The developing acknowledgment of intense consideration beds, basic consideration quaint little inns term beds have expanded the interest for doctor's facility beds. The business sector is developing with high development rate, because of a few variables, for example, developing maturing population, rising social insurance use, expanding pervasiveness of chronic diseases and mechanical progressions in doctor's facility beds. These beds are all around furnished with specific elements that permit patients to change the tallness, and in addition the head and foot segments of the bed. Besides, these components permit better situating of patients, enhanced blood course of patients because of development, simplicity of exchange, and security if there should arise an occurrence of patients, who are at a danger of dropping out of the bed because of the nearness of bed rails.

Browse Details of Report@ https://www.hexaresearch.com/upcoming-research/electrical-hospital-beds-market

Expanding commonness of chronic diseases, development of maturing population and rising medicinal services use drives the business sector of electric beds globally. Increment in chronic diseases prompts an expansion in the quantity of hospitalization cases, fuelling the interest for clinic beds. Also, rising human services consumption overall prompts a change in the social insurance base bringing about development and remodel of healing centers with establishment of new doctor's facility beds. Hence, this drives the worldwide doctor's facility beds market

The innovative progressions in hospital facility beds are further likewise heightening the business sector universally. The electric hospital beds with force sleeping cushions for continuous weight redistribution with fitted electric engine enhance blood flow and aides keeping the development of bed injuries. These propelled highlights offered by these beds make them famous and prompts the development of the business sector around the world.

The maturing population will drive interest for doctor's facility beds, as more individuals require industry items for their medical consideration, including at-home restorative consideration. Moreover, producers will present new items with the most recent advances, for example, coordinated scales and key signs screens, to empower request. In this manner, the Hospital Bed Manufacturing industry's income will keep on growing, in accordance with predictable interest, new advancements and a maturing population.

The normal value that medicinal services offices paid for electric beds was 45% higher in February contrasted and that month a year ago. The expansion was powered by enthusiasm for beds intended for concentrated consideration units. The normal cost paid for electric beds was $15,627, as per the most current information in the Technology Price Index. Higher-cost ICU beds represented 40% of all enthusiasm for electric beds among ECRI part associations, up from 20% amid the same time the prior year. ICU beds tend to cost amongst $25,000 and $30,000 each-fundamentally more than restorative/surgical beds, which regularly cost $5,000 to $10,000 a bed

The key limitations connected with clinic beds business sector is their high cost. High cost of beds declines the reasonableness of individuals in low salary areas. Different hospitals offer several beds, for example, electrical beds, birthing beds, bariatric beds, and basic consideration are to a great degree costly, which makes them excessively expensive for doctor's facilities with restricted spending plan allotted for social insurance. In emerging nations, for example, India, China, and Brazil, manual and semi-electrical beds are favored over electric beds owing to their low cost. High cost of doctor's facility bed is expected to hamper the development of the Electrical Hospital Beds Market

Major players in the Electrical Hospital Beds Market include Linet Invacare Corporation, Hill Rom, Stryker, Getinge AB, Paramount Bed Co. Ltd, Gendron Inc., Span America Medical Systems Inc., and Medline Industries Inc among others.

Browse Related Category Market Reports @

https://www.hexaresearch.com/research-category/healthcare-it-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin: https://www.linkedin.com/company/hexa-research